Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy

NCT02471430 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Panobinostat
DRUG: Pegylated Interferon-alpha2a

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]